...
首页> 外文期刊>Journal of Heterocyclic Chemistry: The International Journal of Heterocyclic Chemistry >Functionalization of Quinazolin-4-ones Part 3: Synthesis, Structures Elucidation, DNA-PK, PI3K, and Cytotoxicity of Novel 8-Aryl-2-morpholino-quinazolin-4-ones
【24h】

Functionalization of Quinazolin-4-ones Part 3: Synthesis, Structures Elucidation, DNA-PK, PI3K, and Cytotoxicity of Novel 8-Aryl-2-morpholino-quinazolin-4-ones

机译:喹唑啉-4-酮的官能化第3部分:合成,结构阐明,DNA-PK,PI3K和新型的8-芳基-2-吗啉基 - 喹唑啉-4-酮的细胞毒性

获取原文
获取原文并翻译 | 示例

摘要

A series of novel 8-aryl-2-morpholino quinazolines (11a-n, 12a-d, 14a-f, and 15) were synthesized from the precursor 2-thioxo quinazolin-4-ones 8. The 8-aryl-2-morpholino quinazolines compounds were assayed for DNA-PK and PI3K. All compounds showed low DNA-PK % inhibition activity at 10 mu M compound concertation, and the most active was 8-(dibenzo[b,d]thiophen-4-yl) 12d with 38% inhibition. Similar pattern of PI3K alpha, beta, gamma, and delta isoforms inhibition activity at 10 mu M were observed. The most active isoform was PI3K delta of 41% inhibition for 8-(dibenzo[b,d]furan-4-yl) compound 11. Most compounds were less active than expected in spite of the strong structural resemblance to known inhibitors (NU7441, 3, 4, and 6). Loss of activity could be attributed to the tautomerization to the aromatic enol (4-OH), which could specify that the important functional group for the activity is the 4-carbonyl (C=O) group. Alternatively, the aromatization of the pyrimidine heterocyclic ring could alter the conformation, and thus binding site, of the 2-morpholine ring, which could reduce the compound-receptor hydrogen bonding to the morpholine 4-oxygen. Selected compounds displayed appreciable cytotoxicity with 6-chloro-8-(dibenzo[b,d]thiophen-4-yl)-2-morpholinoquinazolin-4(1H)-one 11j exhibiting the greatest activity with an IC50 of 9.95 mu M. Therefore, the mechanism of the cytotoxicity of compound 11j were not through DNA-PK or PI3K inhibition activity.
机译:从前体2-硫代氧氧喹唑啉-4-酮中合成了一系列新的8-芳基-2-丙酮氨基唑啉(11a-n,12a-d,14a-f和15)。8-芳基-2-对吗啉喹唑啉化合物用于DNA-PK和PI3K。所有化合物在10μm的化合物吻合下显示出低DNA-PK%抑制活性,最活性为8-(二苯甲苯[B,D]噻吩-4-基)12D,具有38%的抑制作用。观察到类似的PI3Kα,β,γ和Delta同种型抑制活性的类似模式。最活跃的同种型是41%抑制8-(二苯苯基[B,D]呋喃-4-基)化合物11的pi3kδ。尽管与已知抑制剂有强的结构相似性(Nu7441, 3,4和6)。活性损失可归因于芳香烯醇(4-OH)的互变异物,其可以指定活性的重要官能团是4-羰基(C = O)组。或者,嘧啶杂环的芳族化可以改变2 - 吗啉环的构象,因此结合位点,这可以减少与吗啉4-氧的化合物受体氢键合。选择的化合物与6-氯-8-(二苯脲[B,D]噻吩-4-基)-2-morpholinoquinazolin-4(1h)-One 11j显示出具有9.95 mu m的最大活动的最大活动,化合物11J的细胞毒性的机制不是通过DNA-PK或PI3K抑制活性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号